Global Passive Transdermal Drug Delivery Market By Product Type (Microfluidics, Smart Pill Technology (SPT)) And By End-Users/Application (Clinic, Hospital) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985115
  • April 2021
  • Medical Devices
  • 111 Pages

Report Preview

The global Passive Transdermal Drug Delivery market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Passive Transdermal Drug Delivery market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Passive Transdermal Drug Delivery market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Passive Transdermal Drug Delivery market.

Apart from this, the market research report also covers drivers and restraints for the global Passive Transdermal Drug Delivery market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Passive Transdermal Drug Delivery market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Passive Transdermal Drug Delivery market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

XYZ Market Strategic Analysis:
In 2019, the global XYZ market was valued at US$ xx Mn, and it is expected to reach at US$ xx Mn at a CAGR of xx% during 2020-2028.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Passive Transdermal Drug Delivery market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty. 
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Microfluidics, Smart Pill Technology (SPT)
Applications Clinic, Hospital, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp.

Passive Transdermal Drug Delivery Market Segment Analysis:
The Passive Transdermal Drug Delivery market research report segments the market based on its types, applications and end-use industry. All the segments of the market are analyzed and evaluated based on current and future trends of the market. The data for the segments and its categories is provided from 2018 to 2028. 

Passive Transdermal Drug Delivery Market, by Type: Microfluidics, Smart Pill Technology (SPT)

Passive Transdermal Drug Delivery Market, by Application: Clinic, Hospital, Others

Major Key Players for Global Passive Transdermal Drug Delivery Market:
The Passive Transdermal Drug Delivery market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp.

Geographic Coverage for Passive Transdermal Drug Delivery Market:
The market research report on global Passive Transdermal Drug Delivery market offers complete analysis across various regions across the world. The Passive Transdermal Drug Delivery market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Passive Transdermal Drug Delivery market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Passive Transdermal Drug Delivery Market Value and Forecast
  • US
  • Canada

Europe Passive Transdermal Drug Delivery Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe

Asia Pacific Passive Transdermal Drug Delivery Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America Passive Transdermal Drug Delivery Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America

Middle East and Africa Passive Transdermal Drug Delivery Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Key highlights of the Passive Transdermal Drug Delivery market report:
  • The report provides key trends of the global Passive Transdermal Drug Delivery market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Passive Transdermal Drug Delivery industry
  • The report covers all the recent developments of the Passive Transdermal Drug Delivery market and helps to provide current industry updates
  • The report covers a detailed look over the global Passive Transdermal Drug Delivery Industry and provides with significant actionable insights
  • The Passive Transdermal Drug Delivery market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Passive Transdermal Drug Delivery market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Passive Transdermal Drug Delivery market
  • Comprehensive analysis of the Passive Transdermal Drug Delivery market segments based on its types, applications and end-use industry

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Passive Transdermal Drug Delivery market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Passive Transdermal Drug Delivery market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Passive Transdermal Drug Delivery market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Passive Transdermal Drug Delivery market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Passive Transdermal Drug Delivery market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Passive Transdermal Drug Delivery Market Snapshot
          2.1.1. Global Passive Transdermal Drug Delivery Market By Type,2019
               2.1.1.1.Microfluidics
               2.1.1.2.Smart Pill Technology (SPT)
          2.1.2. Global Passive Transdermal Drug Delivery Market By Application,2019
               2.1.2.1.Clinic
               2.1.2.2.Hospital
               2.1.2.3.Others
          2.1.3. Global Passive Transdermal Drug Delivery Market By End-use,2019
          2.1.4. Global Passive Transdermal Drug Delivery Market By Geography,2019

3. Global Passive Transdermal Drug Delivery Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Passive Transdermal Drug Delivery Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Passive Transdermal Drug Delivery Market Size (US$), By Type, 2018 – 2028

5. Global Passive Transdermal Drug Delivery Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Passive Transdermal Drug Delivery Market Size (US$), By Application, 2018 – 2028

6. Global Passive Transdermal Drug Delivery Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Passive Transdermal Drug Delivery Market Size (US$), By End-use, 2018 – 2028

7. Global Passive Transdermal Drug Delivery Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Passive Transdermal Drug Delivery Market Analysis, 2018 – 2028 
          7.2.1. North America Passive Transdermal Drug Delivery Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Passive Transdermal Drug Delivery Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Passive Transdermal Drug Delivery Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Passive Transdermal Drug Delivery Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Passive Transdermal Drug Delivery Market Analysis, 2018 – 2028 
          7.3.1.  Europe Passive Transdermal Drug Delivery Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Passive Transdermal Drug Delivery Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Passive Transdermal Drug Delivery Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Passive Transdermal Drug Delivery Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Passive Transdermal Drug Delivery Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Passive Transdermal Drug Delivery Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Passive Transdermal Drug Delivery Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Passive Transdermal Drug Delivery Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Passive Transdermal Drug Delivery Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Passive Transdermal Drug Delivery Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Passive Transdermal Drug Delivery Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Passive Transdermal Drug Delivery Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Passive Transdermal Drug Delivery Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Passive Transdermal Drug Delivery Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Passive Transdermal Drug Delivery Market Analysis, 2018 – 2028 
          7.6.1.  MEA Passive Transdermal Drug Delivery Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Passive Transdermal Drug Delivery Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Passive Transdermal Drug Delivery Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Passive Transdermal Drug Delivery Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Passive Transdermal Drug Delivery Providers
        8.4.1 3M
                8.1.1 Business Description
                8.1.2 3M Geographic Operations
                8.1.3 3M Financial Information
                8.1.4 3M Product Positions/Portfolio
                8.1.5 3M Key Developments
        8.4.2 Actavis, Inc.
                8.2.1 Business Description
                8.2.2 Actavis, Inc. Geographic Operations
                8.2.3 Actavis, Inc. Financial Information
                8.2.4 Actavis, Inc. Product Positions/Portfolio
                8.2.5 Actavis, Inc. Key Developments
        8.4.3 Bayer AG
                8.3.1 Business Description
                8.3.2 Bayer AG Geographic Operations
                8.3.3 Bayer AG Financial Information
                8.3.4 Bayer AG Product Positions/Portfolio
                8.3.5 Bayer AG Key Developments
        8.4.4 Boehringer Ingelheim GmbH
                8.4.1 Business Description
                8.4.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.3 Boehringer Ingelheim GmbH Financial Information
                8.4.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.5 Boehringer Ingelheim GmbH Key Developments
        8.4.5 Corium International, Inc.
                8.5.1 Business Description
                8.5.2 Corium International, Inc. Geographic Operations
                8.5.3 Corium International, Inc. Financial Information
                8.5.4 Corium International, Inc. Product Positions/Portfolio
                8.5.5 Corium International, Inc. Key Developments
        8.4.6 Echo Therapeutics, Inc.
                8.6.1 Business Description
                8.6.2 Echo Therapeutics, Inc. Geographic Operations
                8.6.3 Echo Therapeutics, Inc. Financial Information
                8.6.4 Echo Therapeutics, Inc. Product Positions/Portfolio
                8.6.5 Echo Therapeutics, Inc. Key Developments
        8.4.7 GlaxoSmithKline plc
                8.7.1 Business Description
                8.7.2 GlaxoSmithKline plc Geographic Operations
                8.7.3 GlaxoSmithKline plc Financial Information
                8.7.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.7.5 GlaxoSmithKline plc Key Developments
        8.4.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
                8.8.1 Business Description
                8.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Geographic Operations
                8.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Financial Information
                8.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Product Positions/Portfolio
                8.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key Developments
        8.4.9 Mylan N.V.
                8.9.1 Business Description
                8.9.2 Mylan N.V. Geographic Operations
                8.9.3 Mylan N.V. Financial Information
                8.9.4 Mylan N.V. Product Positions/Portfolio
                8.9.5 Mylan N.V. Key Developments
        8.4.10 Novartis AG
                8.10.1 Business Description
                8.10.2 Novartis AG Geographic Operations
                8.10.3 Novartis AG Financial Information
                8.10.4 Novartis AG Product Positions/Portfolio
                8.10.5 Novartis AG Key Developments
        8.4.11 Noven Pharmaceuticals, Inc.
                8.11.1 Business Description
                8.11.2 Noven Pharmaceuticals, Inc. Geographic Operations
                8.11.3 Noven Pharmaceuticals, Inc. Financial Information
                8.11.4 Noven Pharmaceuticals, Inc. Product Positions/Portfolio
                8.11.5 Noven Pharmaceuticals, Inc. Key Developments
        8.4.12 Transdermal Corp.
                8.12.1 Business Description
                8.12.2 Transdermal Corp. Geographic Operations
                8.12.3 Transdermal Corp. Financial Information
                8.12.4 Transdermal Corp. Product Positions/Portfolio
                8.12.5 Transdermal Corp. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Passive Transdermal Drug Delivery Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Passive Transdermal Drug Delivery Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Passive Transdermal Drug Delivery Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Passive Transdermal Drug Delivery Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Passive Transdermal Drug Delivery Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Passive Transdermal Drug Delivery Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Passive Transdermal Drug Delivery Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Passive Transdermal Drug Delivery Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Passive Transdermal Drug Delivery Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Passive Transdermal Drug Delivery Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Passive Transdermal Drug Delivery Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Passive Transdermal Drug Delivery Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Passive Transdermal Drug Delivery Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Passive Transdermal Drug Delivery Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Passive Transdermal Drug Delivery Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Passive Transdermal Drug Delivery Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Passive Transdermal Drug Delivery: Market Segmentation 
FIG. 2 Global Passive Transdermal Drug Delivery Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Passive Transdermal Drug Delivery Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Passive Transdermal Drug Delivery Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Passive Transdermal Drug Delivery Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Passive Transdermal Drug Delivery Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Passive Transdermal Drug Delivery Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Passive Transdermal Drug Delivery Providers, 2019
FIG. 11 Global Passive Transdermal Drug Delivery Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Passive Transdermal Drug Delivery Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Passive Transdermal Drug Delivery Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Passive Transdermal Drug Delivery Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Passive Transdermal Drug Delivery Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Passive Transdermal Drug Delivery Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Passive Transdermal Drug Delivery Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Passive Transdermal Drug Delivery Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Passive Transdermal Drug Delivery market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Passive Transdermal Drug Delivery Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Passive Transdermal Drug Delivery Market Value, By Segment1, 2018 – 2028
TABLE  North America Passive Transdermal Drug Delivery Market Value, By Segment2, 2018 – 2028
TABLE  North America Passive Transdermal Drug Delivery Market Value, By Country, 2018 – 2028
TABLE  Europe Passive Transdermal Drug Delivery Market Value, By Segment1, 2018 – 2028
TABLE  Europe Passive Transdermal Drug Delivery Market Value, By Segment2, 2018 – 2028
TABLE  Europe Passive Transdermal Drug Delivery Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Passive Transdermal Drug Delivery Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Passive Transdermal Drug Delivery Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Passive Transdermal Drug Delivery Market Value, By Country, 2018 – 2028
TABLE  Latin America Passive Transdermal Drug Delivery Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Passive Transdermal Drug Delivery Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Passive Transdermal Drug Delivery Market Value, By Country, 2018 – 2028
TABLE  MEA Passive Transdermal Drug Delivery Market Value, By Segment1, 2018 – 2028
TABLE  MEA Passive Transdermal Drug Delivery Market Value, By Segment2, 2018 – 2028
TABLE  MEA Passive Transdermal Drug Delivery Market Value, By Country, 2018 – 2028
TABLE  3M: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Actavis, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Corium International, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Echo Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson (Janssen Pharmaceuticals Inc.): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Noven Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Transdermal Corp.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Passive Transdermal Drug Delivery Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Passive Transdermal Drug Delivery Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Passive Transdermal Drug Delivery Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Passive Transdermal Drug Delivery Market, By Geography, 2019 (US$ Mn)
FIG.  Global Passive Transdermal Drug Delivery Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Passive Transdermal Drug Delivery Providers, 2016
FIG.  Global Passive Transdermal Drug Delivery Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Microfluidics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Smart Pill Technology (SPT) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Passive Transdermal Drug Delivery Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hospital Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Passive Transdermal Drug Delivery Market Value, 2018 – 2028, (US$ Mn)